The effect of HyProCure(®) sinus tarsi stent on tarsal tunnel compartment pressures in hyperpronating feet.
Tarsal tunnel syndrome is characterized by increased pressure in the tarsal tunnel. In hyperpronation, there is excessive abnormal pronation resulting from partial displacement of the talus on the calcaneus. In this study, we hypothesized that hyperpronation caused by talotarsal instability will lead to increased pressure in the tarsal tunnel and porta pedis. We also hypothesized that the pressure in these compartments will decrease following an extra-osseous talotarsal stabilization procedure using HyProCure(®). Pressures in the tarsal tunnel and porta pedis were measured in 9 fresh-frozen cadaver specimens using an intracompartmental pressure monitor system. Pressures were measured with the foot in neutral and hyperpronated position, before and after stabilization using HyProCure. For the tarsal tunnel, pressure in the neutral position with and without HyProCure was 3 ± 3 mm Hg and 4 ± 3 mm Hg, respectively (P = .159). However, for the hyperpronating foot, the pressure decreased from 32 ± 16 mm Hg to 21 ± 10 mm Hg (P < .001) following the placement of HyProCure. In the porta pedis, pressure in the neutral position with and without HyProCure was 2 ± 2 mm Hg and 2 ± 2 mm Hg, respectively (P = .168). However, for the hyperpronating foot, the pressure decreased from 29 ± 15 mm Hg to 18 ± 11 mm Hg (P < .001) following the placement of HyProCure. The pain caused by compression of the posterior tibial nerve in the tarsal tunnel and its branches in the porta pedis, owing to hyperpronation, may be alleviated by implantation of HyProCure.